August 2013

In the August Newsletter, you'll find an update from IASLC President Dr. Peter Goldstraw and IASLC Executive Director Dr. Paul A. Bunn, Jr. The edition also provides information on the recent IASLC election, which establishes the upcoming Officer and Board of Directors; the latest fellowship opportunities; details on IASLC Events; the latest work by IASLC Committees; the latest offer to fellows to join the IASLC and recent new moves by our members.

DENVER – The members of the International Association for the Study of Lung Cancer (IASLC) support tobacco control and smoking cessation efforts across the globe. An editorial published July 20, 2013 in the medical journal Lancet suggests that the government in the United Kingdom has chosen not to pursue standardized packaging because of financial considerations. The editorial suggests that the government in the United Kingdom has sold out to the lobbying interests of major tobacco.

The members of the International Association for the Study of Lung Cancer (IASLC) have selected their new Officers and Board of Directors. The new board members have 151 combined years involved in the IASLC and more than 250 years of experience in lung cancer research. David Carbone, MD, PhD, professor of Internal Medicine and director of the James Thoracic Center at the Ohio State University Wexner Medical Center, was elected President. He will serve as President-Elect until his term as President begins in 2015. David Gandara, MD, professor of Medicine at the University of California, Davis School of Medicine, was elected Treasurer.

The International Association for the Study of Lung Cancer (IASLC) supports the draft lung cancer screening recommendations released by the U.S. Preventive Service Task Force. The Task Force announced Monday its draft recommendation statement on computed tomography (CT) screening.

We are now requesting application for this Fellowship award to be awarded in 2014. The goal is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. The applications will be evaluated by a Scientific Review Panel; the deadline for submission of the application is October 1, 2013. A decision on applications will be reached by October 15, 2013.

June 2013

Election of IASLC officers and members of the Board of Directors are ongoing and the deadline is July 16, 2013.

The World Conference on Lung Cancer in Sydney is coming closer - October 27-30, 2013. A record high number, more than 2,300, of abstracts have been received for the conference and will now be evaluated by the Program Committee. Notification to the abstract authors is scheduled to July 26, 2013. Please, take advantage of the early registration with the deadline of August 2, 2013.